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Effect of biliopancreatic diversion 
on sleep quality and daytime 
sleepiness in patients with 
obesity and type 2 diabetes
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ABSTRACT
Objective: The poor quality of sleep and the deprivation thereof have been associated with disruption 
of metabolic homeostasis, favoring the development of obesity and type 2 diabetes (T2DM). We 
aimed to evaluate the influence of biliopancreatic diversion (BPD) surgery on sleep quality and 
excessive daytime sleepiness of obese patients with T2DM, comparing them with two control groups 
consisting of obese and normal weight individuals, both normal glucose tolerant. Subjects and 
methods: Forty-two women were divided into three groups: LeanControl (n = 11), ObeseControl 
(n = 13), and ObeseT2DM (n = 18). The LeanC and ObeseC groups underwent all tests and evaluations 
once. The ObeseT2DM underwent BPD and were reassessed after 12 months. Pittsburgh Sleep 
Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) were applied before and 12 months after 
BPD. Results: Before surgery, there was less daytime sleepiness in LeanC group (p = 0.013) compared 
with ObeseC and T2DMObese groups. The two obese groups did not differ regarding daytime 
sleepiness, demonstrating that the presence of T2DM had no influence on daytime sleepiness. After 
surgery, the daytime sleepiness (p = 0.002) and the sleep quality (p = 0.033) improved. The score for 
daytime sleepiness of operated T2DMObese group became similar to LeanC and lower than ObeseC 
(p = 0.047). Conclusion: BPD surgery has positively influenced daytime sleepiness and sleep quality 
of obese patients with T2DM, leading to normalization of daytime sleepiness 12 months after surgery. 
These results reinforce previously identified associations between sleep, obesity and T2DM in view 
of the importance of sleep in metabolic homeostasis, quality of life and health. Arch Endocrinol Metab. 
2017;61(6):623-7
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INTRODUCTION
T he growing obesity epidemic has favored the concomitant increase in the prevalence of type 2 
diabetes (T2DM) and sleep disorders (1). Partial sleep 
restriction decreases glucose tolerance, elevates levels of 
serum cortisol, reduces the release of satiety hormone 
leptin and increases the secretion of the hormone 
ghrelin, increasing hunger and appetite (2-5).
Bariatric surgery is a treatment option for obese 
with T2DM who does not achieve adequate metabolic 
control with pharmacological treatment associated 
with changes in life style. Studies with bariatric surgery 
have demonstrated improvement in sleep disorders 
in patients after surgery due to the impact of weight 
reduction (5). The biliopancreatic diversion technique 
(BPD) has a higher percentage of T2DM remission and 
sustained weight loss in the long term (6). In light of 
these questions, we hypothesized that massive surgical 
induced weight loss as observed in BPD surgery 
decreases the level of daytime sleepiness and improves 
sleep quality after long-term weight loss, as previously 
demonstrated in Roux-in-Y gastrectomy and sleeve 
gastrectomy techniques (5,7). 
Given the importance of sleep in metabolic 
homeostasis and the association between sleep quality, 
obesity and T2DM, we aimed: 1) to assess daytime 
sleepiness and sleep quality in obese individuals with 
T2DM, comparing them with two control groups 
consisting of obese and normal weight individuals, 
both normal glucose tolerant (NGT); 2) to evaluate the 
influence of BPD surgery on sleep quality and daytime 
sleepiness; 3) to compare sleep quality and daytime 
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SUBJECTS AND METHODS 
Study design and patients
This study consisted of an experimental group and 
two control groups. We evaluated 42 premenopausal 
women who composed the following groups: 
• Lean Control (LeanC): 11 normal weight (BMI 
= 23 ± 2 kg/m2) NGT;
• Obese Control (ObeseC): 13 obese (BMI = 35 
± 5 kg/m2) NGT;
• Surgical (T2DMObese): 18 obese (BMI = 
35 ± 5 kg/m2) with T2DM undergoing BPD 
surgery. 
The LeanC and ObeseC groups underwent all 
tests and evaluations once. The T2DMObese group 
was evaluated before and 12 months after surgery. 
At the reevaluation, two subjects did not answer the 
sleep questionnaires. Inclusion criteria were: age ≥ 20 
years; weight variation < 5% in the last three months; 
negative for anti-GAD antibody; glycated hemoglobin 
< 10%; not taking insulin and corticosteroids; not using 
medications that alter sleep physiology; no liver and 
renal dysfunction and no recent history of neoplasia.
The protocol was approved by the Ethics Committee 
of the Unicamp. All participants signed the informed 
consent before testing.
Clinical and biochemical evaluation
Demographics, medical history and blood pressure 
data were evaluated and anthropometric assessment 
was performed consisting of BMI, neck and waist 
circumferences. We evaluated body composition through 
the tetrapolar electrical bioimpedance technique. 
The oral glucose tolerance test was performed in 
T2DMObese patients to confirm T2DM diagnosis 
(8). We collected blood samples at baseline and 120 
minutes after ingestion of glucose solution containing 
75 g of glucose for determination of glucose. 
The levels of total cholesterol, HDL-cholesterol and 
triglyceride were measured by enzymatic methods. We 
calculated levels of LDL cholesterol by the Friedewald 
equation. Glycated hemoglobin was determined 
by high performance liquid chromatography. The 
blood glucose levels were measured with the Glucose 
Analyzer YSI 2700. The insulin was determined by 
chemiluminescence. Insulin resistance was assessed by 
HOMA-IR (9) index using measurements of blood 
glucose and fasting insulin.
Biliopancreatic diversion surgery (BPD)
The technique used is an adaptation of the original 
technique (10). The procedure consists of a 60% 
gastric resection with a Roux-en-Y reconstruction. The 
residual stomach volume is around 300 ml. The small 
intestine is transected from 280 to 320 cm from the 
ileocecal valve, and its distal end is anastomosed to the 
remaining stomach. The proximal end of the ileum 
is anastomosed from 80 to 120 cm away from the 
ileocecal valve. The total length of intestinal absorption 
is reduced to 280-300 cm, whose 80-120 cm are called 
final common channel.
Sleep assessment
We used the subjective evaluation method by individual 
application of two questionnaires: Pittsburgh Sleep 
Quality Index (PSQI) (11) and Epworth Sleepiness 
Scale (ESS) (12). The PSQI assesses the overall sleep 
quality for the last month (11), through 7 sleep 
components with weights distributed on a scale from 
0 to 3, with a maximum overall score of 21. The sleep 
components are: subjective sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, sleep disorders, 
sleep medication use, and daytime sleepiness. The ESS 
assesses excessive daytime sleepiness (EDS). The score 
given by the respondent in all situations was summed 
and analyzed. A high score indicates EDS (12).
Statistical analysis
Results were presented in median and interquartile 
range. The Kruskal-Wallis test was used to compare 
the three groups under study. The Duncan post hoc test 
was used to determine which groups differ in relation 
to the others. The Wilcoxon test was used to compare 
the T2DMObese group before and 12 months after 
surgery. The level of significance was p < 0.05.
RESULTS
Clinical and metabolic characteristics at baseline and 
after intervention are shown in Table 1. 
Figure 1 presents the results of the subjective sleep 
evaluation. Before surgery, there was less daytime 
sleepiness in LeanC group (p = 0.013) compared with 
ObeseC and T2DMObese groups. The two obese 
groups did not differ regarding daytime sleepiness, 
demonstrating that the presence of T2DM had no 
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Table 1. Clinical, anthropometric and metabolic characteristics of the study groups lean control, obese control and obese type 2 diabetes
Groups
Characteristics Lean Control  (n = 11)
Obese Control
 (n = 13)
Obese T2DM 
Baseline






Age (years) 29 (25 – 38) 39 (34 – 44) 46 (40 – 50)*,** 0.001 46 (40 – 50) -----
BMI (kg/m2) 23 (21 – 24) 33 (31 – 40) 36(33 – 39)* 0.001 28 (26 – 30) 0.001
Waist circumference (cm) 83 (79 – 85) 105 (101 – 122) 118 (107 – 125)* 0.001 98 (94 – 106) 0.001
Neck circumference (cm) 32.7 (32.7 – 33.3) 36.9 (35.5 – 38.7) 38.8 (37.3 – 40.0)*,** 0.001 35.0 (33.1 – 35.3) 0.036
Body fat (%) 29 (27 – 31) 40 (35 – 44) 42 (38 – 43)* 0.001 34 (31 – 36) 0.012
Systolic blood pressure (mmHg) 110 (100 – 115) 120 (110 – 130) 125 (110 – 140)* 0.024 120 (100 – 120) 0.010
Diastolic blood pressure (mmHg) 70 (70 – 80) 80 (70 – 90) 80 (80 – 90)* 0.080 80 (70 – 80) 0.001
HbA1c (%) 4.3 (4.1 – 4.6) 5.0 (4.5 – 5.5) 7.2 (6.5 – 8.2)*,** 0.001 5.0 (4.8 – 5.4) 0.001
Plasma glucose (mg/dL) 85 (82 – 88) 92 (89 – 97) 127 (112 – 150)*,** 0.001 91 (83 – 97) 0.001
Plasma glucose 2hPC (mg/dL) 99 (92 – 104) 120 (111 – 136) 257 (229 – 292)*,** 0.001 103 (81 – 175) 0.002
Insulin (µU/l) 5.5 (4.4 – 7.8) 7 (6 – 15.4) 13 (8.6 – 18.2)* 0.028 3.4 (2.0 – 12.0) 0.001
HOMA-IR 1.25 (0.9 – 1.62) 1.6 (1.3 – 3.5) 4.0 (2.6 – 5.5)*,** 0.002 0.60 (0.28 – 0.73) 0.001
Total cholesterol (mg/dL) 168 (153 – 184) 173 (159 – 208) 177 (169 – 201) 0.353 137 (117 – 154) 0.001
HDL cholesterol (mg/dL) 60 (50 – 66) 46 (42 – 58) 40 (34 – 44)* 0.001 43 (40 – 48) 0.015
LDL cholesterol (mg/dL) 87 (78 – 110) 105 (93 – 133) 109 (95 – 127) 0.091 62 (54 – 88) 0.001
Triglycerides (mg/dL) 57 (51 – 97) 103 (71 – 154) 124 (110 –185)* 0.001 107 (75 – 142) 0.005
BMI: body mass index. Data presented as median (Interquartile range p25–p75).
a Kruskal-Wallis Test and Duncan post hoc Test (LeanC versus ObeseC versus preoperative Obese T2DM). b Wilcoxon Test. * p < 0.05 vs Lean C; ** p < 0.05 vs ObeseC. 
* p < 0.05 vs Lean Control; ** p < 0.05 vs Obese Control; *** p < 0.05 vs Obese T2DM 
at baseline. 
Figure 1. Comparison of daytime sleepiness (A) and sleep quality scores 
(B) in the three groups before surgery, in the surgical group pre and 
postoperative, and in the three groups after surgery. 
not differ between the three groups in the PSQI global 
score (p = 0.121) (Figure 1B), and also in the analysis of 
individual components of the score (data not shown). 
After surgery, T2DMObese group showed reduced 
daytime sleepiness and improved sleep quality. Regarding 
the PSQI components, the component related to sleep 
disorders showed significant improvement in post-BPD 
(p = 0.034) and there was a trend towards improvement 
in the component related to daytime dysfunction 
(p = 0.075). For the remaining components, there was 
no statistically significant difference. When comparing 
the three groups, the score for daytime sleepiness of 
operated T2DMObese group became similar to LeanC 
and lower than ObeseC (p = 0.047) (Figure 1A). 
For the PSQI questionnaire there was no difference 
in overall sleep quality (Figure 1B), although the 
component related to sleep disorders presented a lower 
score in the post-BPD patients compared with controls 
(p = 0.017).
DISCUSSION
This study is the first to evaluate the effect of BPD 
technique on daytime sleepiness and sleep quality 
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were: 1) obese individuals, independent of T2DM 
presence, presented higher daytime sleepiness than 
normal weight patients with normal glucose tolerance; 
2) BPD decreased daytime sleepiness and improved 
sleep quality; 3) operated subjects showed daytime 
sleepiness normalization, with scores similar to LeanC 
and reduced compared to ObeseC.
Previous studies have shown that obese individuals 
have worse sleep quality compared with normal weight 
individuals (3,5,13,14). Approximately 50% of the obese 
population has daytime sleepiness independent of the 
presence of obstructive sleep apnea. Bidulescu and cols. 
(13), observed higher prevalence of sleep disorders and 
daytime sleepiness in obese women compared with men. 
Another study showed that overweight is associated with 
worse sleep quality assessed by PSQI, especially in adult 
women (14). Short sleep duration is also a risk factor for 
obesity because of its impact on metabolism, increasing 
ghrelin levels and consequently appetite, resulting 
in weight gain; increasing evening  concentrations of 
cortisol and whole body insulin resistance (3,15). 
Clinical and animal studies support the concept that 
obesity can directly contribute to sleepiness. The 
complex interrelationships between circulating systemic 
hormones and neuronal signaling pathways in the central 
nervous system are involved in this process. Obesity and 
metabolic syndrome are related with atypically raised 
basal levels of sympathetic nervous system activity, which 
may have the potential to fragment sleep and contribute 
to daytime sleepiness (16).
In this study, T2DM presence did not influence 
the scores for sleep quality and daytime sleepiness in 
obese individuals. However, studies have shown that 
T2DM presence is associated with worse sleep quality 
(17). Dixon and cols. (18), noted that the ESS scores 
correlated positively and significantly with elevated 
glucose levels. Poor sleep quality and daytime sleepiness 
are reported as a result of metabolic decompensation 
and T2DM deleterious effect on the central mechanism 
of breathing control. Studies have shown the influence 
of sleep disorders on T2DM development, making 
it the cause or effect of sleep disorders (15). Sleep 
deprivation inhibits insulin production due to elevated 
cortisol levels, increasing glucose levels, which can 
aggravate the diabetic condition (19). 
Improved daytime sleepiness in patients undergoing 
BPD has also been observed in clinical studies with 
different techniques in bariatric surgery. In one of these 
studies, preoperative excessive daytime sleepiness was 
reduced from 30% to 5.5% twelve months after surgery. 
Patients with higher reduction in daytime sleepiness 
were those with more significant weight loss (20). In 
the present study, the surgery has improved sleep quality 
assessed by PSQI; however, it did not show a significant 
difference compared with the controls. The small 
number of patients studied may explain this fact, since 
the distribution of scores in the boxplot chart tends to 
decrease. The T2DMObese group showed lower score 
for the sleep disorder component in relation to ObeseC 
and similar to LeanC. A study (7) with gastric bypass 
and sleeve gastrectomy Roux-en-Y techniques showed 
sleep duration increase and consequent improvement 
in overall sleep quality twelve months after surgery. 
In this study, the improvement in sleep quality and 
duration was attributed to the significant weight loss 
(7). Jennings and cols. (21), demonstrated that the 
PSQI global score is positively correlated with BMI 
after adjustment for age among white women. 
In the present study, after BPD surgery, in addition 
to significant weight loss, fat accumulations in the 
abdominal and cervical regions were reduced. Obesity 
results in increased deposition of fat in the neck region, 
including at the base of the tongue and lining the airway, 
especially in the throat. When the airway becomes 
narrowed, respiratory distress increases and may result 
in obstructive sleep apnea (22). In obesity, increased 
neck circumference has been linked to increased risk for 
sleep disorders (23). Our data demonstrate decreased 
neck circumference after surgery, which may have 
contributed to improved daytime sleepiness and sleep 
quality.
Finally, sleep loss also occurs in the presence of 
obstructive sleep apnea. The prevalence of obstructive 
sleep apnea is drastically increased in severe obesity and 
is around 71% in patients admitted for bariatric surgery 
(24). In obstructive sleep apnea patients, cortical micro-
arousals are the main cause of sleep  fragmentation, 
chronic sleep loss, and secondarily increased 
sympathetic  nervous activity (25). The present study 
may have included patients with undiagnosed  sleep 
apnea, and its resolution or improvement may be another 
of the mechanisms that explain the improvement in 
daytime sleepiness and sleep quality.
The present study has some limitations, such as: 
the small number of individuals in each group; the 
use of a single bariatric surgery technique, preventing 
comparisons with other techniques more used in 
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with type 2 diabetes, preventing the assessment 
of the isolate influence of type 2 diabetes on sleep 
quality and daytime sleepiness; and the absence of the 
polysomnography test in the study protocol.
In conclusion, BPD surgery has positively 
influenced daytime sleepiness and sleep quality, leading 
to normalization of daytime sleepiness 12 months after 
surgery. These results reinforce previously observed 
associations between sleep, obesity, and T2DM and 
demonstrate the beneficial effect of BPD on sleeping 
habits of obese patients with T2DM, in view of the 
importance of sleep in metabolic balance, quality of life 
and health.
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